IBDEI01N ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,3585,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,3585,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,3586,0)
;;=E10.9^^26^223^3
;;^UTILITY(U,$J,358.3,3586,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3586,1,3,0)
;;=3^DM1 w/o Complications
;;^UTILITY(U,$J,358.3,3586,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,3586,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,3587,0)
;;=E11.65^^26^223^6
;;^UTILITY(U,$J,358.3,3587,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3587,1,3,0)
;;=3^DM2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,3587,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,3587,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,3588,0)
;;=E11.29^^26^223^10
;;^UTILITY(U,$J,358.3,3588,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3588,1,3,0)
;;=3^DM2 w/ Other Diabetic Kidney Complication
;;^UTILITY(U,$J,358.3,3588,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,3588,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,3589,0)
;;=E11.40^^26^223^8
;;^UTILITY(U,$J,358.3,3589,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3589,1,3,0)
;;=3^DM2 w/ Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,3589,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,3589,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,3590,0)
;;=E11.8^^26^223^14
;;^UTILITY(U,$J,358.3,3590,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3590,1,3,0)
;;=3^DM2 w/ Unspec Complications
;;^UTILITY(U,$J,358.3,3590,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,3590,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,3591,0)
;;=E78.2^^26^223^23
;;^UTILITY(U,$J,358.3,3591,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3591,1,3,0)
;;=3^Mixed Hyperlipidemia
;;^UTILITY(U,$J,358.3,3591,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,3591,2)
;;=^78424
;;^UTILITY(U,$J,358.3,3592,0)
;;=E78.5^^26^223^17
;;^UTILITY(U,$J,358.3,3592,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3592,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,3592,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,3592,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,3593,0)
;;=M10.9^^26^223^16
;;^UTILITY(U,$J,358.3,3593,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3593,1,3,0)
;;=3^Gout,Unspec
;;^UTILITY(U,$J,358.3,3593,1,4,0)
;;=4^M10.9
;;^UTILITY(U,$J,358.3,3593,2)
;;=^5010404
;;^UTILITY(U,$J,358.3,3594,0)
;;=Z79.4^^26^223^21
;;^UTILITY(U,$J,358.3,3594,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3594,1,3,0)
;;=3^Long Term (Current) Use of Insulin
;;^UTILITY(U,$J,358.3,3594,1,4,0)
;;=4^Z79.4
;;^UTILITY(U,$J,358.3,3594,2)
;;=^5063334
;;^UTILITY(U,$J,358.3,3595,0)
;;=Z79.83^^26^223^20
;;^UTILITY(U,$J,358.3,3595,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3595,1,3,0)
;;=3^Long Term (Current) Use of Bisphosphonates
;;^UTILITY(U,$J,358.3,3595,1,4,0)
;;=4^Z79.83
;;^UTILITY(U,$J,358.3,3595,2)
;;=^5063341
;;^UTILITY(U,$J,358.3,3596,0)
;;=E78.00^^26^223^24
;;^UTILITY(U,$J,358.3,3596,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3596,1,3,0)
;;=3^Pure Hypercholesterolemia,Unspec
;;^UTILITY(U,$J,358.3,3596,1,4,0)
;;=4^E78.00
;;^UTILITY(U,$J,358.3,3596,2)
;;=^5138435
;;^UTILITY(U,$J,358.3,3597,0)
;;=E08.9^^26^223^2
;;^UTILITY(U,$J,358.3,3597,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3597,1,3,0)
;;=3^DM d/t Underlying Condition w/o Complications
;;^UTILITY(U,$J,358.3,3597,1,4,0)
;;=4^E08.9
;;^UTILITY(U,$J,358.3,3597,2)
;;=^5002544
;;^UTILITY(U,$J,358.3,3598,0)
;;=E09.9^^26^223^1
;;^UTILITY(U,$J,358.3,3598,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3598,1,3,0)
;;=3^DM d/t Drug/Chemical w/o Complications
;;^UTILITY(U,$J,358.3,3598,1,4,0)
;;=4^E09.9
;;^UTILITY(U,$J,358.3,3598,2)
;;=^5002586
;;^UTILITY(U,$J,358.3,3599,0)
;;=E11.22^^26^223^5
;;^UTILITY(U,$J,358.3,3599,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3599,1,3,0)
;;=3^DM2 w/ CKD
;;^UTILITY(U,$J,358.3,3599,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,3599,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,3600,0)
;;=E11.42^^26^223^13
;;^UTILITY(U,$J,358.3,3600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3600,1,3,0)
;;=3^DM2 w/ Polyneuropathy
;;^UTILITY(U,$J,358.3,3600,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,3600,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,3601,0)
;;=E11.43^^26^223^4
;;^UTILITY(U,$J,358.3,3601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3601,1,3,0)
;;=3^DM2 w/ Autonomic Neuropathy
;;^UTILITY(U,$J,358.3,3601,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,3601,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,3602,0)
;;=E11.51^^26^223^12
;;^UTILITY(U,$J,358.3,3602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3602,1,3,0)
;;=3^DM2 w/ PAD/PVD w/o Gangrene
;;^UTILITY(U,$J,358.3,3602,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,3602,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,3603,0)
;;=E11.52^^26^223^11
;;^UTILITY(U,$J,358.3,3603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3603,1,3,0)
;;=3^DM2 w/ PAD/PVD w/ Gangrene
;;^UTILITY(U,$J,358.3,3603,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,3603,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,3604,0)
;;=E11.59^^26^223^9
;;^UTILITY(U,$J,358.3,3604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3604,1,3,0)
;;=3^DM2 w/ Other Circulatory Complications
;;^UTILITY(U,$J,358.3,3604,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,3604,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,3605,0)
;;=Z79.84^^26^223^22
;;^UTILITY(U,$J,358.3,3605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3605,1,3,0)
;;=3^Long Term (Current) Use of Oral Hypoglycemic Drugs
;;^UTILITY(U,$J,358.3,3605,1,4,0)
;;=4^Z79.84
;;^UTILITY(U,$J,358.3,3605,2)
;;=^5140432
;;^UTILITY(U,$J,358.3,3606,0)
;;=E11.649^^26^223^7
;;^UTILITY(U,$J,358.3,3606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3606,1,3,0)
;;=3^DM2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,3606,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,3606,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,3607,0)
;;=Z79.899^^26^223^19
;;^UTILITY(U,$J,358.3,3607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3607,1,3,0)
;;=3^Long Term (Current) Drug Therapy,Other
;;^UTILITY(U,$J,358.3,3607,1,4,0)
;;=4^Z79.899
;;^UTILITY(U,$J,358.3,3607,2)
;;=^5063343
;;^UTILITY(U,$J,358.3,3608,0)
;;=I25.10^^26^224^4
;;^UTILITY(U,$J,358.3,3608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3608,1,3,0)
;;=3^Athscl Hrt Disease w/o Angina Pectoris
;;^UTILITY(U,$J,358.3,3608,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,3608,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,3609,0)
;;=I25.9^^26^224^26
;;^UTILITY(U,$J,358.3,3609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3609,1,3,0)
;;=3^Ischemic Hrt Disease,Chronic Unspec
;;^UTILITY(U,$J,358.3,3609,1,4,0)
;;=4^I25.9
;;^UTILITY(U,$J,358.3,3609,2)
;;=^5007144
;;^UTILITY(U,$J,358.3,3610,0)
;;=I50.9^^26^224^21
;;^UTILITY(U,$J,358.3,3610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3610,1,3,0)
;;=3^Heart Failure,Unspec
;;^UTILITY(U,$J,358.3,3610,1,4,0)
;;=4^I50.9
;;^UTILITY(U,$J,358.3,3610,2)
;;=^5007251
;;^UTILITY(U,$J,358.3,3611,0)
;;=R03.0^^26^224^12
;;^UTILITY(U,$J,358.3,3611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3611,1,3,0)
;;=3^Elevated B/P w/o Diagnosis of HTN
;;^UTILITY(U,$J,358.3,3611,1,4,0)
;;=4^R03.0
;;^UTILITY(U,$J,358.3,3611,2)
;;=^5019171
;;^UTILITY(U,$J,358.3,3612,0)
;;=E78.2^^26^224^28
;;^UTILITY(U,$J,358.3,3612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3612,1,3,0)
;;=3^Mixed Hyperlipidemia
;;^UTILITY(U,$J,358.3,3612,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,3612,2)
;;=^78424
;;^UTILITY(U,$J,358.3,3613,0)
;;=E78.00^^26^224^29
;;^UTILITY(U,$J,358.3,3613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3613,1,3,0)
;;=3^Pure Hypercholesterolemia,Unspec
;;^UTILITY(U,$J,358.3,3613,1,4,0)
;;=4^E78.00
;;^UTILITY(U,$J,358.3,3613,2)
;;=^5138435
;;^UTILITY(U,$J,358.3,3614,0)
;;=E78.5^^26^224^22
;;^UTILITY(U,$J,358.3,3614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3614,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,3614,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,3614,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,3615,0)
;;=I10.^^26^224^23
;;^UTILITY(U,$J,358.3,3615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3615,1,3,0)
;;=3^Hypertension
;;^UTILITY(U,$J,358.3,3615,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,3615,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,3616,0)
;;=I15.9^^26^224^30
;;^UTILITY(U,$J,358.3,3616,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3616,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,3616,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,3616,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,3617,0)
;;=I25.118^^26^224^5
;;^UTILITY(U,$J,358.3,3617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3617,1,3,0)
;;=3^CAD w/ Other Angina (incl Stable)
;;^UTILITY(U,$J,358.3,3617,1,4,0)
;;=4^I25.118
;;^UTILITY(U,$J,358.3,3617,2)
;;=^5007110
;;^UTILITY(U,$J,358.3,3618,0)
;;=I25.119^^26^224^6
;;^UTILITY(U,$J,358.3,3618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3618,1,3,0)
;;=3^CAD w/ Unspec Angina
;;^UTILITY(U,$J,358.3,3618,1,4,0)
;;=4^I25.119
;;^UTILITY(U,$J,358.3,3618,2)
;;=^5007111
;;^UTILITY(U,$J,358.3,3619,0)
;;=I50.22^^26^224^14
;;^UTILITY(U,$J,358.3,3619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3619,1,3,0)
;;=3^HFrEF,Chronic
;;^UTILITY(U,$J,358.3,3619,1,4,0)
;;=4^I50.22
;;^UTILITY(U,$J,358.3,3619,2)
;;=^5007241
;;^UTILITY(U,$J,358.3,3620,0)
;;=I50.32^^26^224^13
;;^UTILITY(U,$J,358.3,3620,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3620,1,3,0)
;;=3^HFpEF,Chronic
;;^UTILITY(U,$J,358.3,3620,1,4,0)
;;=4^I50.32
;;^UTILITY(U,$J,358.3,3620,2)
;;=^5007245
;;^UTILITY(U,$J,358.3,3621,0)
;;=I50.42^^26^224^11
;;^UTILITY(U,$J,358.3,3621,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3621,1,3,0)
;;=3^Combined Systolic/Diastolic CHF,Chronic
;;^UTILITY(U,$J,358.3,3621,1,4,0)
;;=4^I50.42
;;^UTILITY(U,$J,358.3,3621,2)
;;=^5007249
;;^UTILITY(U,$J,358.3,3622,0)
;;=I11.0^^26^224^24
;;^UTILITY(U,$J,358.3,3622,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3622,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
;;^UTILITY(U,$J,358.3,3622,1,4,0)
;;=4^I11.0
;;^UTILITY(U,$J,358.3,3622,2)
;;=^5007063
;;^UTILITY(U,$J,358.3,3623,0)
;;=I11.9^^26^224^25
;;^UTILITY(U,$J,358.3,3623,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3623,1,3,0)
;;=3^Hypertensive Heart Disease w/o Heart Failure
;;^UTILITY(U,$J,358.3,3623,1,4,0)
;;=4^I11.9
;;^UTILITY(U,$J,358.3,3623,2)
;;=^5007064
;;^UTILITY(U,$J,358.3,3624,0)
;;=I12.0^^26^224^20
;;^UTILITY(U,$J,358.3,3624,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3624,1,3,0)
;;=3^HTN/CKD5 & ESRD
;;^UTILITY(U,$J,358.3,3624,1,4,0)
;;=4^I12.0
;;^UTILITY(U,$J,358.3,3624,2)
;;=^5007065
;;^UTILITY(U,$J,358.3,3625,0)
;;=I12.9^^26^224^19
;;^UTILITY(U,$J,358.3,3625,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3625,1,3,0)
;;=3^HTN/CKD 1-4 or CKD Unspec Stage
;;^UTILITY(U,$J,358.3,3625,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,3625,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,3626,0)
;;=I13.0^^26^224^17
;;^UTILITY(U,$J,358.3,3626,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3626,1,3,0)
;;=3^HTN/CHF/CKD 1-4 or CKD Unspec Stage
;;^UTILITY(U,$J,358.3,3626,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,3626,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,3627,0)
;;=I13.10^^26^224^15
;;^UTILITY(U,$J,358.3,3627,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3627,1,3,0)
;;=3^HTN Heart w/o CHF w/ CKD1-4 or Unspec Stage
;;^UTILITY(U,$J,358.3,3627,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,3627,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,3628,0)
;;=I13.11^^26^224^16
;;^UTILITY(U,$J,358.3,3628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3628,1,3,0)
;;=3^HTN Heart w/o CHF w/ CKD5 or ESRD
;;^UTILITY(U,$J,358.3,3628,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,3628,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,3629,0)
;;=I13.2^^26^224^18
;;^UTILITY(U,$J,358.3,3629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3629,1,3,0)
;;=3^HTN/CHF/CKD5 & ESRD
;;^UTILITY(U,$J,358.3,3629,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,3629,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,3630,0)
;;=I42.0^^26^224^9
;;^UTILITY(U,$J,358.3,3630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3630,1,3,0)
;;=3^Cardiomyopathy,Dilated
;;^UTILITY(U,$J,358.3,3630,1,4,0)
;;=4^I42.0
;;^UTILITY(U,$J,358.3,3630,2)
;;=^5007194
;;^UTILITY(U,$J,358.3,3631,0)
;;=I42.6^^26^224^8
;;^UTILITY(U,$J,358.3,3631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3631,1,3,0)
;;=3^Cardiomyopathy,Alcoholic
;;^UTILITY(U,$J,358.3,3631,1,4,0)
;;=4^I42.6
;;^UTILITY(U,$J,358.3,3631,2)
;;=^5007197
;;^UTILITY(U,$J,358.3,3632,0)
;;=I42.7^^26^224^7
;;^UTILITY(U,$J,358.3,3632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3632,1,3,0)
;;=3^Cardiomyopathy d/t Drug & External Agent
;;^UTILITY(U,$J,358.3,3632,1,4,0)
;;=4^I42.7
;;^UTILITY(U,$J,358.3,3632,2)
;;=^5007198
;;^UTILITY(U,$J,358.3,3633,0)
;;=I42.8^^26^224^10
;;^UTILITY(U,$J,358.3,3633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3633,1,3,0)
;;=3^Cardiomyopathy,Other
;;^UTILITY(U,$J,358.3,3633,1,4,0)
;;=4^I42.8
;;^UTILITY(U,$J,358.3,3633,2)
;;=^5007199
;;^UTILITY(U,$J,358.3,3634,0)
;;=I44.0^^26^224^1
;;^UTILITY(U,$J,358.3,3634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3634,1,3,0)
;;=3^AV Block,1st Degree
;;^UTILITY(U,$J,358.3,3634,1,4,0)
;;=4^I44.0
;;^UTILITY(U,$J,358.3,3634,2)
;;=^5007202
;;^UTILITY(U,$J,358.3,3635,0)
;;=I44.1^^26^224^2
;;^UTILITY(U,$J,358.3,3635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3635,1,3,0)
;;=3^AV Block,2nd Degree
;;^UTILITY(U,$J,358.3,3635,1,4,0)
;;=4^I44.1
;;^UTILITY(U,$J,358.3,3635,2)
;;=^5007203
;;^UTILITY(U,$J,358.3,3636,0)
;;=I44.2^^26^224^3
;;^UTILITY(U,$J,358.3,3636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3636,1,3,0)
;;=3^AV Block,Complete
;;^UTILITY(U,$J,358.3,3636,1,4,0)
;;=4^I44.2
;;^UTILITY(U,$J,358.3,3636,2)
;;=^259621
;;^UTILITY(U,$J,358.3,3637,0)
;;=I44.7^^26^224^27
;;^UTILITY(U,$J,358.3,3637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3637,1,3,0)
;;=3^LBBB,Unspec
;;^UTILITY(U,$J,358.3,3637,1,4,0)
;;=4^I44.7
;;^UTILITY(U,$J,358.3,3637,2)
;;=^5007210
;;^UTILITY(U,$J,358.3,3638,0)
;;=J45.909^^26^225^2
;;^UTILITY(U,$J,358.3,3638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3638,1,3,0)
;;=3^Asthma,Uncomplicated
;;^UTILITY(U,$J,358.3,3638,1,4,0)
;;=4^J45.909
;;^UTILITY(U,$J,358.3,3638,2)
;;=^5008256
;;^UTILITY(U,$J,358.3,3639,0)
;;=J44.9^^26^225^3
;;^UTILITY(U,$J,358.3,3639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3639,1,3,0)
;;=3^COPD
;;^UTILITY(U,$J,358.3,3639,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,3639,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,3640,0)
;;=J18.9^^26^225^5
;;^UTILITY(U,$J,358.3,3640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3640,1,3,0)
;;=3^Pneumonia,Unspec Organism
;;^UTILITY(U,$J,358.3,3640,1,4,0)
;;=4^J18.9
;;^UTILITY(U,$J,358.3,3640,2)
;;=^95632
;;^UTILITY(U,$J,358.3,3641,0)
;;=J30.9^^26^225^1
;;^UTILITY(U,$J,358.3,3641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3641,1,3,0)
;;=3^Allergic Rhinitis,Unspec
;;^UTILITY(U,$J,358.3,3641,1,4,0)
;;=4^J30.9
;;^UTILITY(U,$J,358.3,3641,2)
;;=^5008205
;;^UTILITY(U,$J,358.3,3642,0)
;;=J15.9^^26^225^4
;;^UTILITY(U,$J,358.3,3642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3642,1,3,0)
;;=3^Pneumonia,Bacterial
;;^UTILITY(U,$J,358.3,3642,1,4,0)
;;=4^J15.9
;;^UTILITY(U,$J,358.3,3642,2)
;;=^5008178
;;^UTILITY(U,$J,358.3,3643,0)
;;=C61.^^26^226^32
;;^UTILITY(U,$J,358.3,3643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3643,1,3,0)
;;=3^Malig Neo of Prostate
;;^UTILITY(U,$J,358.3,3643,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,3643,2)
;;=^267239
;;^UTILITY(U,$J,358.3,3644,0)
;;=E55.9^^26^226^42
;;^UTILITY(U,$J,358.3,3644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3644,1,3,0)
;;=3^Vitamin D Deficiency,Unspec
;;^UTILITY(U,$J,358.3,3644,1,4,0)
;;=4^E55.9
;;^UTILITY(U,$J,358.3,3644,2)
;;=^5002799
;;^UTILITY(U,$J,358.3,3645,0)
;;=D63.1^^26^226^9
;;^UTILITY(U,$J,358.3,3645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3645,1,3,0)
;;=3^Anemia in Chr Kidney Disease
;;^UTILITY(U,$J,358.3,3645,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,3645,2)
;;=^332908
;;^UTILITY(U,$J,358.3,3646,0)
;;=D63.8^^26^226^8
;;^UTILITY(U,$J,358.3,3646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3646,1,3,0)
;;=3^Anemia in Chr Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,3646,1,4,0)
;;=4^D63.8
;;^UTILITY(U,$J,358.3,3646,2)
;;=^5002343
;;^UTILITY(U,$J,358.3,3647,0)
;;=D64.9^^26^226^10
;;^UTILITY(U,$J,358.3,3647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3647,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,3647,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,3647,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,3648,0)
;;=F52.21^^26^226^31
;;^UTILITY(U,$J,358.3,3648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3648,1,3,0)
;;=3^Male Erectile Disorder
;;^UTILITY(U,$J,358.3,3648,1,4,0)
;;=4^F52.21
;;^UTILITY(U,$J,358.3,3648,2)
;;=^5003620
;;^UTILITY(U,$J,358.3,3649,0)
;;=F17.200^^26^226^35
;;^UTILITY(U,$J,358.3,3649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3649,1,3,0)
;;=3^Nicotine Dependence,Unspec
;;^UTILITY(U,$J,358.3,3649,1,4,0)
;;=4^F17.200
;;^UTILITY(U,$J,358.3,3649,2)
;;=^5003360
;;^UTILITY(U,$J,358.3,3650,0)
;;=F17.210^^26^226^34
;;^UTILITY(U,$J,358.3,3650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3650,1,3,0)
;;=3^Nicotine Dependence,Cigarettes
;;^UTILITY(U,$J,358.3,3650,1,4,0)
;;=4^F17.210
;;^UTILITY(U,$J,358.3,3650,2)
;;=^5003365
;;^UTILITY(U,$J,358.3,3651,0)
;;=K21.9^^26^226^19
;;^UTILITY(U,$J,358.3,3651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3651,1,3,0)
;;=3^GERD w/o Esophagitis
;;^UTILITY(U,$J,358.3,3651,1,4,0)
;;=4^K21.9
;;^UTILITY(U,$J,358.3,3651,2)
;;=^5008505
;;^UTILITY(U,$J,358.3,3652,0)
;;=N18.6^^26^226^14
;;^UTILITY(U,$J,358.3,3652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3652,1,3,0)
;;=3^ESRD
;;^UTILITY(U,$J,358.3,3652,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,3652,2)
;;=^303986
;;^UTILITY(U,$J,358.3,3653,0)
;;=N40.0^^26^226^16
;;^UTILITY(U,$J,358.3,3653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3653,1,3,0)
;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,3653,1,4,0)
;;=4^N40.0
;;^UTILITY(U,$J,358.3,3653,2)
;;=^5015689
;;^UTILITY(U,$J,358.3,3654,0)
;;=R82.5^^26^226^15
;;^UTILITY(U,$J,358.3,3654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3654,1,3,0)
;;=3^Elevated Urine Levels of Drug/Meds/Bio Subst
;;^UTILITY(U,$J,358.3,3654,1,4,0)
;;=4^R82.5
;;^UTILITY(U,$J,358.3,3654,2)
;;=^5019605
;;^UTILITY(U,$J,358.3,3655,0)
;;=R82.6^^26^226^3
;;^UTILITY(U,$J,358.3,3655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3655,1,3,0)
;;=3^Abnormal Urine Levels of Non-Medicinal Subs
;;^UTILITY(U,$J,358.3,3655,1,4,0)
;;=4^R82.6
;;^UTILITY(U,$J,358.3,3655,2)
;;=^5019606
;;^UTILITY(U,$J,358.3,3656,0)
;;=R89.2^^26^226^1
;;^UTILITY(U,$J,358.3,3656,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,3656,1,3,0)
;;=3^Abnormal Drug/Meds/Bio Subs Level in Org/Tiss Specimens
;;^UTILITY(U,$J,358.3,3656,1,4,0)
;;=4^R89.2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI01N 19750 printed Nov 22, 2024@16:50:03 Page 2
IBDEI01N ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,3585,1,4,0)
+2 ;;=4^E11.9
+3 ;;^UTILITY(U,$J,358.3,3585,2)
+4 ;;=^5002666
+5 ;;^UTILITY(U,$J,358.3,3586,0)
+6 ;;=E10.9^^26^223^3
+7 ;;^UTILITY(U,$J,358.3,3586,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,3586,1,3,0)
+10 ;;=3^DM1 w/o Complications
+11 ;;^UTILITY(U,$J,358.3,3586,1,4,0)
+12 ;;=4^E10.9
+13 ;;^UTILITY(U,$J,358.3,3586,2)
+14 ;;=^5002626
+15 ;;^UTILITY(U,$J,358.3,3587,0)
+16 ;;=E11.65^^26^223^6
+17 ;;^UTILITY(U,$J,358.3,3587,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,3587,1,3,0)
+20 ;;=3^DM2 w/ Hyperglycemia
+21 ;;^UTILITY(U,$J,358.3,3587,1,4,0)
+22 ;;=4^E11.65
+23 ;;^UTILITY(U,$J,358.3,3587,2)
+24 ;;=^5002663
+25 ;;^UTILITY(U,$J,358.3,3588,0)
+26 ;;=E11.29^^26^223^10
+27 ;;^UTILITY(U,$J,358.3,3588,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,3588,1,3,0)
+30 ;;=3^DM2 w/ Other Diabetic Kidney Complication
+31 ;;^UTILITY(U,$J,358.3,3588,1,4,0)
+32 ;;=4^E11.29
+33 ;;^UTILITY(U,$J,358.3,3588,2)
+34 ;;=^5002631
+35 ;;^UTILITY(U,$J,358.3,3589,0)
+36 ;;=E11.40^^26^223^8
+37 ;;^UTILITY(U,$J,358.3,3589,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,3589,1,3,0)
+40 ;;=3^DM2 w/ Neuropathy,Unspec
+41 ;;^UTILITY(U,$J,358.3,3589,1,4,0)
+42 ;;=4^E11.40
+43 ;;^UTILITY(U,$J,358.3,3589,2)
+44 ;;=^5002644
+45 ;;^UTILITY(U,$J,358.3,3590,0)
+46 ;;=E11.8^^26^223^14
+47 ;;^UTILITY(U,$J,358.3,3590,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,3590,1,3,0)
+50 ;;=3^DM2 w/ Unspec Complications
+51 ;;^UTILITY(U,$J,358.3,3590,1,4,0)
+52 ;;=4^E11.8
+53 ;;^UTILITY(U,$J,358.3,3590,2)
+54 ;;=^5002665
+55 ;;^UTILITY(U,$J,358.3,3591,0)
+56 ;;=E78.2^^26^223^23
+57 ;;^UTILITY(U,$J,358.3,3591,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,3591,1,3,0)
+60 ;;=3^Mixed Hyperlipidemia
+61 ;;^UTILITY(U,$J,358.3,3591,1,4,0)
+62 ;;=4^E78.2
+63 ;;^UTILITY(U,$J,358.3,3591,2)
+64 ;;=^78424
+65 ;;^UTILITY(U,$J,358.3,3592,0)
+66 ;;=E78.5^^26^223^17
+67 ;;^UTILITY(U,$J,358.3,3592,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,3592,1,3,0)
+70 ;;=3^Hyperlipidemia,Unspec
+71 ;;^UTILITY(U,$J,358.3,3592,1,4,0)
+72 ;;=4^E78.5
+73 ;;^UTILITY(U,$J,358.3,3592,2)
+74 ;;=^5002969
+75 ;;^UTILITY(U,$J,358.3,3593,0)
+76 ;;=M10.9^^26^223^16
+77 ;;^UTILITY(U,$J,358.3,3593,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,3593,1,3,0)
+80 ;;=3^Gout,Unspec
+81 ;;^UTILITY(U,$J,358.3,3593,1,4,0)
+82 ;;=4^M10.9
+83 ;;^UTILITY(U,$J,358.3,3593,2)
+84 ;;=^5010404
+85 ;;^UTILITY(U,$J,358.3,3594,0)
+86 ;;=Z79.4^^26^223^21
+87 ;;^UTILITY(U,$J,358.3,3594,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,3594,1,3,0)
+90 ;;=3^Long Term (Current) Use of Insulin
+91 ;;^UTILITY(U,$J,358.3,3594,1,4,0)
+92 ;;=4^Z79.4
+93 ;;^UTILITY(U,$J,358.3,3594,2)
+94 ;;=^5063334
+95 ;;^UTILITY(U,$J,358.3,3595,0)
+96 ;;=Z79.83^^26^223^20
+97 ;;^UTILITY(U,$J,358.3,3595,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,3595,1,3,0)
+100 ;;=3^Long Term (Current) Use of Bisphosphonates
+101 ;;^UTILITY(U,$J,358.3,3595,1,4,0)
+102 ;;=4^Z79.83
+103 ;;^UTILITY(U,$J,358.3,3595,2)
+104 ;;=^5063341
+105 ;;^UTILITY(U,$J,358.3,3596,0)
+106 ;;=E78.00^^26^223^24
+107 ;;^UTILITY(U,$J,358.3,3596,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,3596,1,3,0)
+110 ;;=3^Pure Hypercholesterolemia,Unspec
+111 ;;^UTILITY(U,$J,358.3,3596,1,4,0)
+112 ;;=4^E78.00
+113 ;;^UTILITY(U,$J,358.3,3596,2)
+114 ;;=^5138435
+115 ;;^UTILITY(U,$J,358.3,3597,0)
+116 ;;=E08.9^^26^223^2
+117 ;;^UTILITY(U,$J,358.3,3597,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,3597,1,3,0)
+120 ;;=3^DM d/t Underlying Condition w/o Complications
+121 ;;^UTILITY(U,$J,358.3,3597,1,4,0)
+122 ;;=4^E08.9
+123 ;;^UTILITY(U,$J,358.3,3597,2)
+124 ;;=^5002544
+125 ;;^UTILITY(U,$J,358.3,3598,0)
+126 ;;=E09.9^^26^223^1
+127 ;;^UTILITY(U,$J,358.3,3598,1,0)
+128 ;;=^358.31IA^4^2
+129 ;;^UTILITY(U,$J,358.3,3598,1,3,0)
+130 ;;=3^DM d/t Drug/Chemical w/o Complications
+131 ;;^UTILITY(U,$J,358.3,3598,1,4,0)
+132 ;;=4^E09.9
+133 ;;^UTILITY(U,$J,358.3,3598,2)
+134 ;;=^5002586
+135 ;;^UTILITY(U,$J,358.3,3599,0)
+136 ;;=E11.22^^26^223^5
+137 ;;^UTILITY(U,$J,358.3,3599,1,0)
+138 ;;=^358.31IA^4^2
+139 ;;^UTILITY(U,$J,358.3,3599,1,3,0)
+140 ;;=3^DM2 w/ CKD
+141 ;;^UTILITY(U,$J,358.3,3599,1,4,0)
+142 ;;=4^E11.22
+143 ;;^UTILITY(U,$J,358.3,3599,2)
+144 ;;=^5002630
+145 ;;^UTILITY(U,$J,358.3,3600,0)
+146 ;;=E11.42^^26^223^13
+147 ;;^UTILITY(U,$J,358.3,3600,1,0)
+148 ;;=^358.31IA^4^2
+149 ;;^UTILITY(U,$J,358.3,3600,1,3,0)
+150 ;;=3^DM2 w/ Polyneuropathy
+151 ;;^UTILITY(U,$J,358.3,3600,1,4,0)
+152 ;;=4^E11.42
+153 ;;^UTILITY(U,$J,358.3,3600,2)
+154 ;;=^5002646
+155 ;;^UTILITY(U,$J,358.3,3601,0)
+156 ;;=E11.43^^26^223^4
+157 ;;^UTILITY(U,$J,358.3,3601,1,0)
+158 ;;=^358.31IA^4^2
+159 ;;^UTILITY(U,$J,358.3,3601,1,3,0)
+160 ;;=3^DM2 w/ Autonomic Neuropathy
+161 ;;^UTILITY(U,$J,358.3,3601,1,4,0)
+162 ;;=4^E11.43
+163 ;;^UTILITY(U,$J,358.3,3601,2)
+164 ;;=^5002647
+165 ;;^UTILITY(U,$J,358.3,3602,0)
+166 ;;=E11.51^^26^223^12
+167 ;;^UTILITY(U,$J,358.3,3602,1,0)
+168 ;;=^358.31IA^4^2
+169 ;;^UTILITY(U,$J,358.3,3602,1,3,0)
+170 ;;=3^DM2 w/ PAD/PVD w/o Gangrene
+171 ;;^UTILITY(U,$J,358.3,3602,1,4,0)
+172 ;;=4^E11.51
+173 ;;^UTILITY(U,$J,358.3,3602,2)
+174 ;;=^5002650
+175 ;;^UTILITY(U,$J,358.3,3603,0)
+176 ;;=E11.52^^26^223^11
+177 ;;^UTILITY(U,$J,358.3,3603,1,0)
+178 ;;=^358.31IA^4^2
+179 ;;^UTILITY(U,$J,358.3,3603,1,3,0)
+180 ;;=3^DM2 w/ PAD/PVD w/ Gangrene
+181 ;;^UTILITY(U,$J,358.3,3603,1,4,0)
+182 ;;=4^E11.52
+183 ;;^UTILITY(U,$J,358.3,3603,2)
+184 ;;=^5002651
+185 ;;^UTILITY(U,$J,358.3,3604,0)
+186 ;;=E11.59^^26^223^9
+187 ;;^UTILITY(U,$J,358.3,3604,1,0)
+188 ;;=^358.31IA^4^2
+189 ;;^UTILITY(U,$J,358.3,3604,1,3,0)
+190 ;;=3^DM2 w/ Other Circulatory Complications
+191 ;;^UTILITY(U,$J,358.3,3604,1,4,0)
+192 ;;=4^E11.59
+193 ;;^UTILITY(U,$J,358.3,3604,2)
+194 ;;=^5002652
+195 ;;^UTILITY(U,$J,358.3,3605,0)
+196 ;;=Z79.84^^26^223^22
+197 ;;^UTILITY(U,$J,358.3,3605,1,0)
+198 ;;=^358.31IA^4^2
+199 ;;^UTILITY(U,$J,358.3,3605,1,3,0)
+200 ;;=3^Long Term (Current) Use of Oral Hypoglycemic Drugs
+201 ;;^UTILITY(U,$J,358.3,3605,1,4,0)
+202 ;;=4^Z79.84
+203 ;;^UTILITY(U,$J,358.3,3605,2)
+204 ;;=^5140432
+205 ;;^UTILITY(U,$J,358.3,3606,0)
+206 ;;=E11.649^^26^223^7
+207 ;;^UTILITY(U,$J,358.3,3606,1,0)
+208 ;;=^358.31IA^4^2
+209 ;;^UTILITY(U,$J,358.3,3606,1,3,0)
+210 ;;=3^DM2 w/ Hypoglycemia w/o Coma
+211 ;;^UTILITY(U,$J,358.3,3606,1,4,0)
+212 ;;=4^E11.649
+213 ;;^UTILITY(U,$J,358.3,3606,2)
+214 ;;=^5002662
+215 ;;^UTILITY(U,$J,358.3,3607,0)
+216 ;;=Z79.899^^26^223^19
+217 ;;^UTILITY(U,$J,358.3,3607,1,0)
+218 ;;=^358.31IA^4^2
+219 ;;^UTILITY(U,$J,358.3,3607,1,3,0)
+220 ;;=3^Long Term (Current) Drug Therapy,Other
+221 ;;^UTILITY(U,$J,358.3,3607,1,4,0)
+222 ;;=4^Z79.899
+223 ;;^UTILITY(U,$J,358.3,3607,2)
+224 ;;=^5063343
+225 ;;^UTILITY(U,$J,358.3,3608,0)
+226 ;;=I25.10^^26^224^4
+227 ;;^UTILITY(U,$J,358.3,3608,1,0)
+228 ;;=^358.31IA^4^2
+229 ;;^UTILITY(U,$J,358.3,3608,1,3,0)
+230 ;;=3^Athscl Hrt Disease w/o Angina Pectoris
+231 ;;^UTILITY(U,$J,358.3,3608,1,4,0)
+232 ;;=4^I25.10
+233 ;;^UTILITY(U,$J,358.3,3608,2)
+234 ;;=^5007107
+235 ;;^UTILITY(U,$J,358.3,3609,0)
+236 ;;=I25.9^^26^224^26
+237 ;;^UTILITY(U,$J,358.3,3609,1,0)
+238 ;;=^358.31IA^4^2
+239 ;;^UTILITY(U,$J,358.3,3609,1,3,0)
+240 ;;=3^Ischemic Hrt Disease,Chronic Unspec
+241 ;;^UTILITY(U,$J,358.3,3609,1,4,0)
+242 ;;=4^I25.9
+243 ;;^UTILITY(U,$J,358.3,3609,2)
+244 ;;=^5007144
+245 ;;^UTILITY(U,$J,358.3,3610,0)
+246 ;;=I50.9^^26^224^21
+247 ;;^UTILITY(U,$J,358.3,3610,1,0)
+248 ;;=^358.31IA^4^2
+249 ;;^UTILITY(U,$J,358.3,3610,1,3,0)
+250 ;;=3^Heart Failure,Unspec
+251 ;;^UTILITY(U,$J,358.3,3610,1,4,0)
+252 ;;=4^I50.9
+253 ;;^UTILITY(U,$J,358.3,3610,2)
+254 ;;=^5007251
+255 ;;^UTILITY(U,$J,358.3,3611,0)
+256 ;;=R03.0^^26^224^12
+257 ;;^UTILITY(U,$J,358.3,3611,1,0)
+258 ;;=^358.31IA^4^2
+259 ;;^UTILITY(U,$J,358.3,3611,1,3,0)
+260 ;;=3^Elevated B/P w/o Diagnosis of HTN
+261 ;;^UTILITY(U,$J,358.3,3611,1,4,0)
+262 ;;=4^R03.0
+263 ;;^UTILITY(U,$J,358.3,3611,2)
+264 ;;=^5019171
+265 ;;^UTILITY(U,$J,358.3,3612,0)
+266 ;;=E78.2^^26^224^28
+267 ;;^UTILITY(U,$J,358.3,3612,1,0)
+268 ;;=^358.31IA^4^2
+269 ;;^UTILITY(U,$J,358.3,3612,1,3,0)
+270 ;;=3^Mixed Hyperlipidemia
+271 ;;^UTILITY(U,$J,358.3,3612,1,4,0)
+272 ;;=4^E78.2
+273 ;;^UTILITY(U,$J,358.3,3612,2)
+274 ;;=^78424
+275 ;;^UTILITY(U,$J,358.3,3613,0)
+276 ;;=E78.00^^26^224^29
+277 ;;^UTILITY(U,$J,358.3,3613,1,0)
+278 ;;=^358.31IA^4^2
+279 ;;^UTILITY(U,$J,358.3,3613,1,3,0)
+280 ;;=3^Pure Hypercholesterolemia,Unspec
+281 ;;^UTILITY(U,$J,358.3,3613,1,4,0)
+282 ;;=4^E78.00
+283 ;;^UTILITY(U,$J,358.3,3613,2)
+284 ;;=^5138435
+285 ;;^UTILITY(U,$J,358.3,3614,0)
+286 ;;=E78.5^^26^224^22
+287 ;;^UTILITY(U,$J,358.3,3614,1,0)
+288 ;;=^358.31IA^4^2
+289 ;;^UTILITY(U,$J,358.3,3614,1,3,0)
+290 ;;=3^Hyperlipidemia,Unspec
+291 ;;^UTILITY(U,$J,358.3,3614,1,4,0)
+292 ;;=4^E78.5
+293 ;;^UTILITY(U,$J,358.3,3614,2)
+294 ;;=^5002969
+295 ;;^UTILITY(U,$J,358.3,3615,0)
+296 ;;=I10.^^26^224^23
+297 ;;^UTILITY(U,$J,358.3,3615,1,0)
+298 ;;=^358.31IA^4^2
+299 ;;^UTILITY(U,$J,358.3,3615,1,3,0)
+300 ;;=3^Hypertension
+301 ;;^UTILITY(U,$J,358.3,3615,1,4,0)
+302 ;;=4^I10.
+303 ;;^UTILITY(U,$J,358.3,3615,2)
+304 ;;=^5007062
+305 ;;^UTILITY(U,$J,358.3,3616,0)
+306 ;;=I15.9^^26^224^30
+307 ;;^UTILITY(U,$J,358.3,3616,1,0)
+308 ;;=^358.31IA^4^2
+309 ;;^UTILITY(U,$J,358.3,3616,1,3,0)
+310 ;;=3^Secondary Hypertension,Unspec
+311 ;;^UTILITY(U,$J,358.3,3616,1,4,0)
+312 ;;=4^I15.9
+313 ;;^UTILITY(U,$J,358.3,3616,2)
+314 ;;=^5007075
+315 ;;^UTILITY(U,$J,358.3,3617,0)
+316 ;;=I25.118^^26^224^5
+317 ;;^UTILITY(U,$J,358.3,3617,1,0)
+318 ;;=^358.31IA^4^2
+319 ;;^UTILITY(U,$J,358.3,3617,1,3,0)
+320 ;;=3^CAD w/ Other Angina (incl Stable)
+321 ;;^UTILITY(U,$J,358.3,3617,1,4,0)
+322 ;;=4^I25.118
+323 ;;^UTILITY(U,$J,358.3,3617,2)
+324 ;;=^5007110
+325 ;;^UTILITY(U,$J,358.3,3618,0)
+326 ;;=I25.119^^26^224^6
+327 ;;^UTILITY(U,$J,358.3,3618,1,0)
+328 ;;=^358.31IA^4^2
+329 ;;^UTILITY(U,$J,358.3,3618,1,3,0)
+330 ;;=3^CAD w/ Unspec Angina
+331 ;;^UTILITY(U,$J,358.3,3618,1,4,0)
+332 ;;=4^I25.119
+333 ;;^UTILITY(U,$J,358.3,3618,2)
+334 ;;=^5007111
+335 ;;^UTILITY(U,$J,358.3,3619,0)
+336 ;;=I50.22^^26^224^14
+337 ;;^UTILITY(U,$J,358.3,3619,1,0)
+338 ;;=^358.31IA^4^2
+339 ;;^UTILITY(U,$J,358.3,3619,1,3,0)
+340 ;;=3^HFrEF,Chronic
+341 ;;^UTILITY(U,$J,358.3,3619,1,4,0)
+342 ;;=4^I50.22
+343 ;;^UTILITY(U,$J,358.3,3619,2)
+344 ;;=^5007241
+345 ;;^UTILITY(U,$J,358.3,3620,0)
+346 ;;=I50.32^^26^224^13
+347 ;;^UTILITY(U,$J,358.3,3620,1,0)
+348 ;;=^358.31IA^4^2
+349 ;;^UTILITY(U,$J,358.3,3620,1,3,0)
+350 ;;=3^HFpEF,Chronic
+351 ;;^UTILITY(U,$J,358.3,3620,1,4,0)
+352 ;;=4^I50.32
+353 ;;^UTILITY(U,$J,358.3,3620,2)
+354 ;;=^5007245
+355 ;;^UTILITY(U,$J,358.3,3621,0)
+356 ;;=I50.42^^26^224^11
+357 ;;^UTILITY(U,$J,358.3,3621,1,0)
+358 ;;=^358.31IA^4^2
+359 ;;^UTILITY(U,$J,358.3,3621,1,3,0)
+360 ;;=3^Combined Systolic/Diastolic CHF,Chronic
+361 ;;^UTILITY(U,$J,358.3,3621,1,4,0)
+362 ;;=4^I50.42
+363 ;;^UTILITY(U,$J,358.3,3621,2)
+364 ;;=^5007249
+365 ;;^UTILITY(U,$J,358.3,3622,0)
+366 ;;=I11.0^^26^224^24
+367 ;;^UTILITY(U,$J,358.3,3622,1,0)
+368 ;;=^358.31IA^4^2
+369 ;;^UTILITY(U,$J,358.3,3622,1,3,0)
+370 ;;=3^Hypertensive Heart Disease w/ Heart Failure
+371 ;;^UTILITY(U,$J,358.3,3622,1,4,0)
+372 ;;=4^I11.0
+373 ;;^UTILITY(U,$J,358.3,3622,2)
+374 ;;=^5007063
+375 ;;^UTILITY(U,$J,358.3,3623,0)
+376 ;;=I11.9^^26^224^25
+377 ;;^UTILITY(U,$J,358.3,3623,1,0)
+378 ;;=^358.31IA^4^2
+379 ;;^UTILITY(U,$J,358.3,3623,1,3,0)
+380 ;;=3^Hypertensive Heart Disease w/o Heart Failure
+381 ;;^UTILITY(U,$J,358.3,3623,1,4,0)
+382 ;;=4^I11.9
+383 ;;^UTILITY(U,$J,358.3,3623,2)
+384 ;;=^5007064
+385 ;;^UTILITY(U,$J,358.3,3624,0)
+386 ;;=I12.0^^26^224^20
+387 ;;^UTILITY(U,$J,358.3,3624,1,0)
+388 ;;=^358.31IA^4^2
+389 ;;^UTILITY(U,$J,358.3,3624,1,3,0)
+390 ;;=3^HTN/CKD5 & ESRD
+391 ;;^UTILITY(U,$J,358.3,3624,1,4,0)
+392 ;;=4^I12.0
+393 ;;^UTILITY(U,$J,358.3,3624,2)
+394 ;;=^5007065
+395 ;;^UTILITY(U,$J,358.3,3625,0)
+396 ;;=I12.9^^26^224^19
+397 ;;^UTILITY(U,$J,358.3,3625,1,0)
+398 ;;=^358.31IA^4^2
+399 ;;^UTILITY(U,$J,358.3,3625,1,3,0)
+400 ;;=3^HTN/CKD 1-4 or CKD Unspec Stage
+401 ;;^UTILITY(U,$J,358.3,3625,1,4,0)
+402 ;;=4^I12.9
+403 ;;^UTILITY(U,$J,358.3,3625,2)
+404 ;;=^5007066
+405 ;;^UTILITY(U,$J,358.3,3626,0)
+406 ;;=I13.0^^26^224^17
+407 ;;^UTILITY(U,$J,358.3,3626,1,0)
+408 ;;=^358.31IA^4^2
+409 ;;^UTILITY(U,$J,358.3,3626,1,3,0)
+410 ;;=3^HTN/CHF/CKD 1-4 or CKD Unspec Stage
+411 ;;^UTILITY(U,$J,358.3,3626,1,4,0)
+412 ;;=4^I13.0
+413 ;;^UTILITY(U,$J,358.3,3626,2)
+414 ;;=^5007067
+415 ;;^UTILITY(U,$J,358.3,3627,0)
+416 ;;=I13.10^^26^224^15
+417 ;;^UTILITY(U,$J,358.3,3627,1,0)
+418 ;;=^358.31IA^4^2
+419 ;;^UTILITY(U,$J,358.3,3627,1,3,0)
+420 ;;=3^HTN Heart w/o CHF w/ CKD1-4 or Unspec Stage
+421 ;;^UTILITY(U,$J,358.3,3627,1,4,0)
+422 ;;=4^I13.10
+423 ;;^UTILITY(U,$J,358.3,3627,2)
+424 ;;=^5007068
+425 ;;^UTILITY(U,$J,358.3,3628,0)
+426 ;;=I13.11^^26^224^16
+427 ;;^UTILITY(U,$J,358.3,3628,1,0)
+428 ;;=^358.31IA^4^2
+429 ;;^UTILITY(U,$J,358.3,3628,1,3,0)
+430 ;;=3^HTN Heart w/o CHF w/ CKD5 or ESRD
+431 ;;^UTILITY(U,$J,358.3,3628,1,4,0)
+432 ;;=4^I13.11
+433 ;;^UTILITY(U,$J,358.3,3628,2)
+434 ;;=^5007069
+435 ;;^UTILITY(U,$J,358.3,3629,0)
+436 ;;=I13.2^^26^224^18
+437 ;;^UTILITY(U,$J,358.3,3629,1,0)
+438 ;;=^358.31IA^4^2
+439 ;;^UTILITY(U,$J,358.3,3629,1,3,0)
+440 ;;=3^HTN/CHF/CKD5 & ESRD
+441 ;;^UTILITY(U,$J,358.3,3629,1,4,0)
+442 ;;=4^I13.2
+443 ;;^UTILITY(U,$J,358.3,3629,2)
+444 ;;=^5007070
+445 ;;^UTILITY(U,$J,358.3,3630,0)
+446 ;;=I42.0^^26^224^9
+447 ;;^UTILITY(U,$J,358.3,3630,1,0)
+448 ;;=^358.31IA^4^2
+449 ;;^UTILITY(U,$J,358.3,3630,1,3,0)
+450 ;;=3^Cardiomyopathy,Dilated
+451 ;;^UTILITY(U,$J,358.3,3630,1,4,0)
+452 ;;=4^I42.0
+453 ;;^UTILITY(U,$J,358.3,3630,2)
+454 ;;=^5007194
+455 ;;^UTILITY(U,$J,358.3,3631,0)
+456 ;;=I42.6^^26^224^8
+457 ;;^UTILITY(U,$J,358.3,3631,1,0)
+458 ;;=^358.31IA^4^2
+459 ;;^UTILITY(U,$J,358.3,3631,1,3,0)
+460 ;;=3^Cardiomyopathy,Alcoholic
+461 ;;^UTILITY(U,$J,358.3,3631,1,4,0)
+462 ;;=4^I42.6
+463 ;;^UTILITY(U,$J,358.3,3631,2)
+464 ;;=^5007197
+465 ;;^UTILITY(U,$J,358.3,3632,0)
+466 ;;=I42.7^^26^224^7
+467 ;;^UTILITY(U,$J,358.3,3632,1,0)
+468 ;;=^358.31IA^4^2
+469 ;;^UTILITY(U,$J,358.3,3632,1,3,0)
+470 ;;=3^Cardiomyopathy d/t Drug & External Agent
+471 ;;^UTILITY(U,$J,358.3,3632,1,4,0)
+472 ;;=4^I42.7
+473 ;;^UTILITY(U,$J,358.3,3632,2)
+474 ;;=^5007198
+475 ;;^UTILITY(U,$J,358.3,3633,0)
+476 ;;=I42.8^^26^224^10
+477 ;;^UTILITY(U,$J,358.3,3633,1,0)
+478 ;;=^358.31IA^4^2
+479 ;;^UTILITY(U,$J,358.3,3633,1,3,0)
+480 ;;=3^Cardiomyopathy,Other
+481 ;;^UTILITY(U,$J,358.3,3633,1,4,0)
+482 ;;=4^I42.8
+483 ;;^UTILITY(U,$J,358.3,3633,2)
+484 ;;=^5007199
+485 ;;^UTILITY(U,$J,358.3,3634,0)
+486 ;;=I44.0^^26^224^1
+487 ;;^UTILITY(U,$J,358.3,3634,1,0)
+488 ;;=^358.31IA^4^2
+489 ;;^UTILITY(U,$J,358.3,3634,1,3,0)
+490 ;;=3^AV Block,1st Degree
+491 ;;^UTILITY(U,$J,358.3,3634,1,4,0)
+492 ;;=4^I44.0
+493 ;;^UTILITY(U,$J,358.3,3634,2)
+494 ;;=^5007202
+495 ;;^UTILITY(U,$J,358.3,3635,0)
+496 ;;=I44.1^^26^224^2
+497 ;;^UTILITY(U,$J,358.3,3635,1,0)
+498 ;;=^358.31IA^4^2
+499 ;;^UTILITY(U,$J,358.3,3635,1,3,0)
+500 ;;=3^AV Block,2nd Degree
+501 ;;^UTILITY(U,$J,358.3,3635,1,4,0)
+502 ;;=4^I44.1
+503 ;;^UTILITY(U,$J,358.3,3635,2)
+504 ;;=^5007203
+505 ;;^UTILITY(U,$J,358.3,3636,0)
+506 ;;=I44.2^^26^224^3
+507 ;;^UTILITY(U,$J,358.3,3636,1,0)
+508 ;;=^358.31IA^4^2
+509 ;;^UTILITY(U,$J,358.3,3636,1,3,0)
+510 ;;=3^AV Block,Complete
+511 ;;^UTILITY(U,$J,358.3,3636,1,4,0)
+512 ;;=4^I44.2
+513 ;;^UTILITY(U,$J,358.3,3636,2)
+514 ;;=^259621
+515 ;;^UTILITY(U,$J,358.3,3637,0)
+516 ;;=I44.7^^26^224^27
+517 ;;^UTILITY(U,$J,358.3,3637,1,0)
+518 ;;=^358.31IA^4^2
+519 ;;^UTILITY(U,$J,358.3,3637,1,3,0)
+520 ;;=3^LBBB,Unspec
+521 ;;^UTILITY(U,$J,358.3,3637,1,4,0)
+522 ;;=4^I44.7
+523 ;;^UTILITY(U,$J,358.3,3637,2)
+524 ;;=^5007210
+525 ;;^UTILITY(U,$J,358.3,3638,0)
+526 ;;=J45.909^^26^225^2
+527 ;;^UTILITY(U,$J,358.3,3638,1,0)
+528 ;;=^358.31IA^4^2
+529 ;;^UTILITY(U,$J,358.3,3638,1,3,0)
+530 ;;=3^Asthma,Uncomplicated
+531 ;;^UTILITY(U,$J,358.3,3638,1,4,0)
+532 ;;=4^J45.909
+533 ;;^UTILITY(U,$J,358.3,3638,2)
+534 ;;=^5008256
+535 ;;^UTILITY(U,$J,358.3,3639,0)
+536 ;;=J44.9^^26^225^3
+537 ;;^UTILITY(U,$J,358.3,3639,1,0)
+538 ;;=^358.31IA^4^2
+539 ;;^UTILITY(U,$J,358.3,3639,1,3,0)
+540 ;;=3^COPD
+541 ;;^UTILITY(U,$J,358.3,3639,1,4,0)
+542 ;;=4^J44.9
+543 ;;^UTILITY(U,$J,358.3,3639,2)
+544 ;;=^5008241
+545 ;;^UTILITY(U,$J,358.3,3640,0)
+546 ;;=J18.9^^26^225^5
+547 ;;^UTILITY(U,$J,358.3,3640,1,0)
+548 ;;=^358.31IA^4^2
+549 ;;^UTILITY(U,$J,358.3,3640,1,3,0)
+550 ;;=3^Pneumonia,Unspec Organism
+551 ;;^UTILITY(U,$J,358.3,3640,1,4,0)
+552 ;;=4^J18.9
+553 ;;^UTILITY(U,$J,358.3,3640,2)
+554 ;;=^95632
+555 ;;^UTILITY(U,$J,358.3,3641,0)
+556 ;;=J30.9^^26^225^1
+557 ;;^UTILITY(U,$J,358.3,3641,1,0)
+558 ;;=^358.31IA^4^2
+559 ;;^UTILITY(U,$J,358.3,3641,1,3,0)
+560 ;;=3^Allergic Rhinitis,Unspec
+561 ;;^UTILITY(U,$J,358.3,3641,1,4,0)
+562 ;;=4^J30.9
+563 ;;^UTILITY(U,$J,358.3,3641,2)
+564 ;;=^5008205
+565 ;;^UTILITY(U,$J,358.3,3642,0)
+566 ;;=J15.9^^26^225^4
+567 ;;^UTILITY(U,$J,358.3,3642,1,0)
+568 ;;=^358.31IA^4^2
+569 ;;^UTILITY(U,$J,358.3,3642,1,3,0)
+570 ;;=3^Pneumonia,Bacterial
+571 ;;^UTILITY(U,$J,358.3,3642,1,4,0)
+572 ;;=4^J15.9
+573 ;;^UTILITY(U,$J,358.3,3642,2)
+574 ;;=^5008178
+575 ;;^UTILITY(U,$J,358.3,3643,0)
+576 ;;=C61.^^26^226^32
+577 ;;^UTILITY(U,$J,358.3,3643,1,0)
+578 ;;=^358.31IA^4^2
+579 ;;^UTILITY(U,$J,358.3,3643,1,3,0)
+580 ;;=3^Malig Neo of Prostate
+581 ;;^UTILITY(U,$J,358.3,3643,1,4,0)
+582 ;;=4^C61.
+583 ;;^UTILITY(U,$J,358.3,3643,2)
+584 ;;=^267239
+585 ;;^UTILITY(U,$J,358.3,3644,0)
+586 ;;=E55.9^^26^226^42
+587 ;;^UTILITY(U,$J,358.3,3644,1,0)
+588 ;;=^358.31IA^4^2
+589 ;;^UTILITY(U,$J,358.3,3644,1,3,0)
+590 ;;=3^Vitamin D Deficiency,Unspec
+591 ;;^UTILITY(U,$J,358.3,3644,1,4,0)
+592 ;;=4^E55.9
+593 ;;^UTILITY(U,$J,358.3,3644,2)
+594 ;;=^5002799
+595 ;;^UTILITY(U,$J,358.3,3645,0)
+596 ;;=D63.1^^26^226^9
+597 ;;^UTILITY(U,$J,358.3,3645,1,0)
+598 ;;=^358.31IA^4^2
+599 ;;^UTILITY(U,$J,358.3,3645,1,3,0)
+600 ;;=3^Anemia in Chr Kidney Disease
+601 ;;^UTILITY(U,$J,358.3,3645,1,4,0)
+602 ;;=4^D63.1
+603 ;;^UTILITY(U,$J,358.3,3645,2)
+604 ;;=^332908
+605 ;;^UTILITY(U,$J,358.3,3646,0)
+606 ;;=D63.8^^26^226^8
+607 ;;^UTILITY(U,$J,358.3,3646,1,0)
+608 ;;=^358.31IA^4^2
+609 ;;^UTILITY(U,$J,358.3,3646,1,3,0)
+610 ;;=3^Anemia in Chr Diseases Classified Elsewhere
+611 ;;^UTILITY(U,$J,358.3,3646,1,4,0)
+612 ;;=4^D63.8
+613 ;;^UTILITY(U,$J,358.3,3646,2)
+614 ;;=^5002343
+615 ;;^UTILITY(U,$J,358.3,3647,0)
+616 ;;=D64.9^^26^226^10
+617 ;;^UTILITY(U,$J,358.3,3647,1,0)
+618 ;;=^358.31IA^4^2
+619 ;;^UTILITY(U,$J,358.3,3647,1,3,0)
+620 ;;=3^Anemia,Unspec
+621 ;;^UTILITY(U,$J,358.3,3647,1,4,0)
+622 ;;=4^D64.9
+623 ;;^UTILITY(U,$J,358.3,3647,2)
+624 ;;=^5002351
+625 ;;^UTILITY(U,$J,358.3,3648,0)
+626 ;;=F52.21^^26^226^31
+627 ;;^UTILITY(U,$J,358.3,3648,1,0)
+628 ;;=^358.31IA^4^2
+629 ;;^UTILITY(U,$J,358.3,3648,1,3,0)
+630 ;;=3^Male Erectile Disorder
+631 ;;^UTILITY(U,$J,358.3,3648,1,4,0)
+632 ;;=4^F52.21
+633 ;;^UTILITY(U,$J,358.3,3648,2)
+634 ;;=^5003620
+635 ;;^UTILITY(U,$J,358.3,3649,0)
+636 ;;=F17.200^^26^226^35
+637 ;;^UTILITY(U,$J,358.3,3649,1,0)
+638 ;;=^358.31IA^4^2
+639 ;;^UTILITY(U,$J,358.3,3649,1,3,0)
+640 ;;=3^Nicotine Dependence,Unspec
+641 ;;^UTILITY(U,$J,358.3,3649,1,4,0)
+642 ;;=4^F17.200
+643 ;;^UTILITY(U,$J,358.3,3649,2)
+644 ;;=^5003360
+645 ;;^UTILITY(U,$J,358.3,3650,0)
+646 ;;=F17.210^^26^226^34
+647 ;;^UTILITY(U,$J,358.3,3650,1,0)
+648 ;;=^358.31IA^4^2
+649 ;;^UTILITY(U,$J,358.3,3650,1,3,0)
+650 ;;=3^Nicotine Dependence,Cigarettes
+651 ;;^UTILITY(U,$J,358.3,3650,1,4,0)
+652 ;;=4^F17.210
+653 ;;^UTILITY(U,$J,358.3,3650,2)
+654 ;;=^5003365
+655 ;;^UTILITY(U,$J,358.3,3651,0)
+656 ;;=K21.9^^26^226^19
+657 ;;^UTILITY(U,$J,358.3,3651,1,0)
+658 ;;=^358.31IA^4^2
+659 ;;^UTILITY(U,$J,358.3,3651,1,3,0)
+660 ;;=3^GERD w/o Esophagitis
+661 ;;^UTILITY(U,$J,358.3,3651,1,4,0)
+662 ;;=4^K21.9
+663 ;;^UTILITY(U,$J,358.3,3651,2)
+664 ;;=^5008505
+665 ;;^UTILITY(U,$J,358.3,3652,0)
+666 ;;=N18.6^^26^226^14
+667 ;;^UTILITY(U,$J,358.3,3652,1,0)
+668 ;;=^358.31IA^4^2
+669 ;;^UTILITY(U,$J,358.3,3652,1,3,0)
+670 ;;=3^ESRD
+671 ;;^UTILITY(U,$J,358.3,3652,1,4,0)
+672 ;;=4^N18.6
+673 ;;^UTILITY(U,$J,358.3,3652,2)
+674 ;;=^303986
+675 ;;^UTILITY(U,$J,358.3,3653,0)
+676 ;;=N40.0^^26^226^16
+677 ;;^UTILITY(U,$J,358.3,3653,1,0)
+678 ;;=^358.31IA^4^2
+679 ;;^UTILITY(U,$J,358.3,3653,1,3,0)
+680 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
+681 ;;^UTILITY(U,$J,358.3,3653,1,4,0)
+682 ;;=4^N40.0
+683 ;;^UTILITY(U,$J,358.3,3653,2)
+684 ;;=^5015689
+685 ;;^UTILITY(U,$J,358.3,3654,0)
+686 ;;=R82.5^^26^226^15
+687 ;;^UTILITY(U,$J,358.3,3654,1,0)
+688 ;;=^358.31IA^4^2
+689 ;;^UTILITY(U,$J,358.3,3654,1,3,0)
+690 ;;=3^Elevated Urine Levels of Drug/Meds/Bio Subst
+691 ;;^UTILITY(U,$J,358.3,3654,1,4,0)
+692 ;;=4^R82.5
+693 ;;^UTILITY(U,$J,358.3,3654,2)
+694 ;;=^5019605
+695 ;;^UTILITY(U,$J,358.3,3655,0)
+696 ;;=R82.6^^26^226^3
+697 ;;^UTILITY(U,$J,358.3,3655,1,0)
+698 ;;=^358.31IA^4^2
+699 ;;^UTILITY(U,$J,358.3,3655,1,3,0)
+700 ;;=3^Abnormal Urine Levels of Non-Medicinal Subs
+701 ;;^UTILITY(U,$J,358.3,3655,1,4,0)
+702 ;;=4^R82.6
+703 ;;^UTILITY(U,$J,358.3,3655,2)
+704 ;;=^5019606
+705 ;;^UTILITY(U,$J,358.3,3656,0)
+706 ;;=R89.2^^26^226^1
+707 ;;^UTILITY(U,$J,358.3,3656,1,0)
+708 ;;=^358.31IA^4^2
+709 ;;^UTILITY(U,$J,358.3,3656,1,3,0)
+710 ;;=3^Abnormal Drug/Meds/Bio Subs Level in Org/Tiss Specimens
+711 ;;^UTILITY(U,$J,358.3,3656,1,4,0)
+712 ;;=4^R89.2
